BCRX BioCryst Pharmaceuticals

• None no insider bought on the open market
• $605K sold by 2 insiders outside a trading plan
• $3.5M sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Amy E McKee Director
   Sale
   $100K 11,180 shares at $8.97 26% of stake
   Traded May 18 Filed May 19
   ↗
3. Alane P Barnes Chief Legal Officer
   Planned sale
   $596K 62,500 shares at $9.54 14% of stake
   Traded May 13 Filed May 15
   ↗
4. Theresa Heggie Director
   Sale
   $505K 49,933 shares at $10.11 43% of stake
   Traded Mar 20 Filed Mar 24
   ↗
5. Alane P Barnes Chief Legal Officer
   Planned sale
   $1.4M 150,000 shares at $9.15 27% of stake
   Traded Mar 16 Filed Mar 18
   ↗
6. Alane P Barnes Chief Legal Officer
   Planned sale
   $167K 21,773 shares at $7.65 5.2% of stake
   Traded Dec 22, 2025 Filed Dec 23, 2025
   ↗
7. Alane P Barnes Chief Legal Officer
   Planned sale
   $162K 21,210 shares at $7.65 6.3% of stake
   Traded Dec 15, 2025 Filed Dec 16, 2025
   ↗
8. Alane P Barnes Chief Legal Officer
   Planned sale
   $1.2M 161,680 shares at $7.21 32% of stake
   Traded Dec 1–3 Filed Dec 3, 2025
   ↗
9. Machelle Sanders Director
   Planned sale
   $69K 9,600 shares at $7.14 24% of stake
   Traded Nov 13, 2025 Filed Nov 17, 2025
   ↗

Also filed in the last 12 months, not counted as buying or selling: 33 stock grants, 8 option exercises, 6 share withholdings for taxes, 3 gifts, and 1 sale back to the company.